Skip to main content

Table 2 Simulation experiments performed through NetLogo framework. We limited the in silico testing of the vaccination protocols only to them that are free form possible side-effects (as highlighted from preliminary safety in vivo testing) and that showed in silico the best humoral response evaluated by the IgG titers dynamics

From: Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus

Test

Adjuvants

Day of administration

a

adj1

0 and 14

b

adj1

0 and 21

c

adj1

0 and 28

d

adj2

0 and 14

e

adj2

0 and 21

f

adj2

0 and 28

g

adj3

0 and 14

h

adj3

0 and 21

i

adj3

0 and 28

l

adj1 + adj2

0 and 14

m

adj1 + adj2

0 and 21

n

adj1 + adj2

0 and 28

o

adj2 + adj3

0 and 14

p

adj2 + adj3

0 and 21

q

adj2 + adj3

0 and 28

r

adj1 + adj3

0 and 14

s

adj1 + adj3

0 and 21

t

adj1 + adj3

0 and 28